Merus (MRUS) Stock Forecast & Price Target

$42.93 -0.56 (-1.29%)

(As of 11/20/2024 ET)

Merus - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 14 Analyst Ratings

Sell
0

Hold
0

Buy
14

Based on 14 Wall Street analysts who have issued ratings for Merus in the last 12 months, the stock has a consensus rating of "Buy." Out of the 14 analysts, 12 have given a buy rating, and 2 have given a strong buy rating for MRUS.

Consensus Price Target

$85.45
99.06% Upside

According to the 14 analysts' twelve-month price targets for Merus, the average price target is $85.45. The highest price target for MRUS is $111.00, while the lowest price target for MRUS is $67.00. The average price target represents a forecasted upside of 99.06% from the current price of $42.93.

Get the Latest News and Ratings for MRUS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Merus and its competitors.

MRUS Analyst Ratings Over Time

Type	Current Forecast 11/22/23 to 11/21/24	1 Month Ago 10/23/23 to 10/22/24	3 Months Ago 8/24/23 to 8/23/24	1 Year Ago 11/22/22 to 11/22/23
Strong Buy	2 Strong Buy rating(s)	2 Strong Buy rating(s)	2 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	12 Buy rating(s)	10 Buy rating(s)	10 Buy rating(s)	11 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$85.45	$82.00	$80.20	$44.90
Forecasted Upside	99.06% Upside	54.16% Upside	49.65% Upside	89.93% Upside
Consensus Rating	Buy	Buy	Buy	Buy

Financial Prophecy (Ad)

The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.

MRUS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MRUS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Merus Stock vs. The Competition

Type	Merus	Medical Companies	S&P 500
Consensus Rating Score	3.15	2.80	2.50
Consensus Rating	Buy	Moderate Buy	Moderate Buy
Predicted Upside	101.96% Upside	26,931.55% Upside	9.81% Upside
News Sentiment Rating	Positive News See Recent MRUS News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/21/2024	The Goldman Sachs Group 2 of 5 stars		Initiated Coverage	Buy	$73.00	+70.04%
11/20/2024	Needham & Company LLC 2 of 5 stars		Reiterated Rating	Buy ➝ Buy	$85.00 ➝ $85.00	+95.45%
11/1/2024	HC Wainwright 2 of 5 stars		Reiterated Rating	Buy ➝ Buy	$85.00 ➝ $85.00	+70.24%
10/24/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Dai Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$72.00	+37.64%
10/1/2024	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$93.00 ➝ $111.00	+117.99%
7/29/2024	Lifesci Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Zhu Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
Get the Latest News and Ratings for MRUS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Merus and its competitors with MarketBeat's FREE daily newsletter.
7/25/2024	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Newman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
6/26/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$70.00 ➝ $93.00	+63.70%
6/25/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$76.00 ➝ $76.00	+35.52%
6/17/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$90.00 ➝ $99.00	+75.07%
6/4/2024	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$84.00 ➝ $91.00	+71.70%
6/4/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$69.00 ➝ $88.00	+66.23%
4/22/2024	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform
8/21/2023	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform
4/17/2023	SVB Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform	$35.00 ➝ $48.00	+95.04%
4/14/2023	EF Hutton Acquisition Co. I Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy	$35.00	+41.24%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 08:04 AM ET.

MRUS Forecast - Frequently Asked Questions

: According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Merus is $85.45, with a high forecast of $111.00 and a low forecast of $67.00.
: 14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Merus in the last twelve months. There are currently 12 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MRUS shares.
: According to analysts, Merus's stock has a predicted upside of 99.06% based on their 12-month stock forecasts.
: Merus has been rated by research analysts at Guggenheim, HC Wainwright, Needham & Company LLC, The Goldman Sachs Group, and UBS Group in the past 90 days.
: Analysts like Merus more than other "medical" companies. The consensus rating for Merus is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how MRUS compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Financial Prophecy (Ad)

Including the name of the #1 company to buy.

This page (NASDAQ:MRUS) was last updated on 11/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Merus (MRUS) Stock Forecast & Price Target